MAL-PDT for difficult to treat nonmelanoma skin cancer. - Wikidata - awgldk - TriplyDB

MAL-PDT for difficult to treat nonmelanoma skin cancer.

MAL-PDT for difficult to treat nonmelanoma skin cancer.

http://www.wikidata.org/entity/Q33806297

about

Long-term outcomes following Foscan®-PDT of basal cell carcinomas.A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer.Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends.

P2860

Q34360733-D2A32A64-69AA-452E-955F-A1BA12CC7485 Q35068326-43B1879E-F883-4390-813F-7C60CDE731DF Q38271835-4288CE45-4B58-44BD-B117-67E02FE2EB88

P2860

MAL-PDT for difficult to treat nonmelanoma skin cancer.

http://www.wikidata.org/entity/Q33806297

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

MAL-PDT for difficult to treat nonmelanoma skin cancer.

@ast

MAL-PDT for difficult to treat nonmelanoma skin cancer.

@en

type

label

MAL-PDT for difficult to treat nonmelanoma skin cancer.

@ast

MAL-PDT for difficult to treat nonmelanoma skin cancer.

@en

prefLabel

MAL-PDT for difficult to treat nonmelanoma skin cancer.

@ast

MAL-PDT for difficult to treat nonmelanoma skin cancer.

@en

P1433

Q33806297-F68CE44D-FE58-4A4B-9493-F4079CA4E856

P1476

Q33806297-FDD3F9DD-8B96-484B-B05A-96005FD0A3C9

P2093

Q33806297-8B890EBE-AAB5-4442-9FF0-539CE76AC5E6

Q33806297-BE673C0C-79E6-4054-990B-E909FF0E1A02

P2860

Q33806297-05141B6E-81AB-48EA-8B10-81D688C6FC4D

Q33806297-08920592-BAA0-4CD6-8681-2D387E14876A

Q33806297-0AA2E8E1-95DD-404C-A11B-ACE94E3E0F95

Q33806297-0CA8CE99-B0CE-4C94-A522-58060D6FA99D

Q33806297-122A2E1F-F08F-4B83-993E-AFF00A0F581C

Q33806297-186A2EC1-0816-4817-AB54-3A0DCCABB050

Q33806297-255D82D4-456A-499F-84F8-4D0E21BC4031

Q33806297-2C7ADD32-BBEA-4A33-820B-5A32E32B0F71

Q33806297-3BFCF1A6-3C5C-40BD-A45B-5F11C5069C93

Q33806297-43FCBBA1-6620-4985-99AA-17467F467095

P304

Q33806297-E7D6BD54-65CE-447D-A4F2-C5B9E2191D81

P31

Q33806297-9A5AFFC1-53A8-4423-AD9B-BED1B2D68CA5

P356

Q33806297-023BE8CF-DD87-4376-8EEA-A068078B055B

P433

Q33806297-71C43ADC-CA6A-43FE-BCE3-D432A5E0B534

P478

Q33806297-21679DBE-E981-48DB-92BD-F38DB9885628

P577

Q33806297-B21D7A39-2CDE-4B32-A807-5743E9A7D7CB

P698

Q33806297-BF8A0564-BA1F-4F61-9401-0440537D6597

P356

J.1529-8019.2010.01381.X

P1433

Dermatologic Therapy

P1476

MAL-PDT for difficult to treat nonmelanoma skin cancer.

@en

P2093

C William Hanke

http://www.w3.org/2001/XMLSchema#string

William G Stebbins

http://www.w3.org/2001/XMLSchema#string

P2860

Laser and non-laser light sources for photodynamic therapy.

Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources.

Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.

Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging.

Photodynamic therapy in dermatology: a review.

Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment.

Low density lipoprotein receptor and cation-independent mannose 6-phosphate receptor are transported from the cell surface to the Golgi apparatus at equal rates in PC12 cells.

Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.

Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours.

Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.

P304

82-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1529-8019.2010.01381.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21276161

http://www.w3.org/2001/XMLSchema#string